Correlation Between Simulations Plus and 10X Genomics
Can any of the company-specific risk be diversified away by investing in both Simulations Plus and 10X Genomics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Simulations Plus and 10X Genomics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Simulations Plus and 10X Genomics, you can compare the effects of market volatilities on Simulations Plus and 10X Genomics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Simulations Plus with a short position of 10X Genomics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Simulations Plus and 10X Genomics.
Diversification Opportunities for Simulations Plus and 10X Genomics
0.52 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Simulations and 10X is 0.52. Overlapping area represents the amount of risk that can be diversified away by holding Simulations Plus and 10X Genomics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on 10X Genomics and Simulations Plus is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Simulations Plus are associated (or correlated) with 10X Genomics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of 10X Genomics has no effect on the direction of Simulations Plus i.e., Simulations Plus and 10X Genomics go up and down completely randomly.
Pair Corralation between Simulations Plus and 10X Genomics
Considering the 90-day investment horizon Simulations Plus is expected to generate 0.64 times more return on investment than 10X Genomics. However, Simulations Plus is 1.56 times less risky than 10X Genomics. It trades about -0.04 of its potential returns per unit of risk. 10X Genomics is currently generating about -0.1 per unit of risk. If you would invest 3,609 in Simulations Plus on August 28, 2024 and sell it today you would lose (335.00) from holding Simulations Plus or give up 9.28% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Simulations Plus vs. 10X Genomics
Performance |
| Timeline |
| Simulations Plus |
| 10X Genomics |
Simulations Plus and 10X Genomics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Simulations Plus and 10X Genomics
The main advantage of trading using opposite Simulations Plus and 10X Genomics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Simulations Plus position performs unexpectedly, 10X Genomics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 10X Genomics will offset losses from the drop in 10X Genomics' long position.| Simulations Plus vs. Definitive Healthcare Corp | Simulations Plus vs. National Research Corp | Simulations Plus vs. Evolent Health | Simulations Plus vs. Privia Health Group |
| 10X Genomics vs. Twist Bioscience Corp | 10X Genomics vs. Fate Therapeutics | 10X Genomics vs. Beam Therapeutics | 10X Genomics vs. Veracyte |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |